Medication info
Teneldim Extended-Release Tablet 10/500 mg

Teneldim Extended-Release Tablet 10/500 mg

Prescription medicationTabletOral
Ingredient · strength
Teneligliptin Hydrochloride Hydrate›13mg / 1 tabletMetformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
Kukje Pharmaceutical Co., Ltd.
Appearance
Orange egg-shaped extended-release film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202201411 · Approved 2022.04.04 · Insurance code 643705300

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The dose of this medicine should be determined based on each patient's current treatment, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose is titrated gradually to reduce gastrointestinal adverse reactions associated with metformin. Take 1 tablet of this medicine 20/1000mg extended-release tablet once daily. Patients taking this medicine 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients who cannot achieve adequate glycemic control with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current dose of metformin. For patients switching to this medicine from combination therapy with teneligliptin and metformin, treatment with this medicine may be started at their previous doses of teneligliptin and metformin. When switching from immediate-release metformin to the extended-release formulation, glycemic control should be closely monitored and the dose adjusted appropriately. When coadministered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from other glucose-lowering medicines. Because changes may lead to alterations in glycemic control, any change in treatment for patients with type 2 diabetes should be made under close monitoring. To maintain its extended-release properties, this medicine should be swallowed whole and not split, crushed, ground, or chewed.

Ingredients

Manufacturer
Kukje Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes mellitus

View approved original text

This medication is used to assist patients with type 2 diabetes in controlling their blood glucose levels. When administered in conjunction with dietary and exercise therapy, it helps manage blood glucose levels effectively. The two active ingredients, teneligliptin and metformin, work together to enhance blood glucose control. This can lead to positive outcomes in diabetes management.

How to take

Adult dose

The dose of this medicine should be determined based on each patient's current treatment, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose is titrated gradually to reduce gastrointestinal adverse reactions associated with metformin. Take 1 tablet of this medicine 20/1000mg extended-release tablet once daily. Patients taking this medicine 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients who cannot achieve adequate glycemic control with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current dose of metformin. For patients switching to this medicine from combination therapy with teneligliptin and metformin, treatment with this medicine may be started at their previous doses of teneligliptin and metformin. When switching from immediate-release metformin to the extended-release formulation, glycemic control should be closely monitored and the dose adjusted appropriately. When coadministered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from other glucose-lowering medicines. Because changes may lead to alterations in glycemic control, any change in treatment for patients with type 2 diabetes should be made under close monitoring. To maintain its extended-release properties, this medicine should be swallowed whole and not split, crushed, ground, or chewed.

Precautions

This medication is used to control blood glucose and should not be administered to patients with impaired kidney function or severe heart failure. Additionally, it should be temporarily discontinued in cases of acute renal failure, severe infections, or before and after surgery, and can be resumed only after kidney function has returned to normal. It can lead to a rare but serious side effect called lactic acidosis, which is more likely to occur in circumstances of diminished kidney function, liver dysfunction, severe dehydration, or cardiopulmonary disease. Symptoms of lactic acidosis may include fatigue, muscle pain, dyspnea, and abdominal pain, and should prompt immediate consultation with a physician. When combined with other diabetes medications, this drug may increase the risk of hypoglycemia, so patients should be aware of symptoms and management strategies for hypoglycemia. Moreover, excessive alcohol consumption can elevate the risk of lactic acidosis, so it is advisable to avoid drinking alcohol. Patients should have regular kidney function and blood tests while taking this medication, and it is particularly important to monitor vitamin B12 levels. It is safe for pregnant women or those who may become pregnant, as well as breastfeeding women, to refrain from using this medication. If symptoms such as dizziness, abdominal pain, skin rash, or dyspnea occur, medical attention should be sought immediately. Elderly patients may have reduced kidney function; therefore, dosage adjustments and regular monitoring may be necessary. During the course of this medication, any sudden vomiting, diarrhea, or dehydration symptoms should prompt a consultation with a physician to adjust the medication as necessary. Care should be taken during driving or performing tasks requiring concentration due to the risk of hypoglycemia or dizziness.

Side effects

  • Severe metabolic acidosis
  • hypoglycemia
  • intestinal obstruction
  • liver dysfunction
  • interstitial pneumonia
  • erythema multiforme
  • acute pancreatitis
  • dizziness
  • constipation
  • abdominal distension
Show 113 more
  • abdominal discomfort
  • nausea
  • abdominal pain
  • flatulence
  • stomatitis
  • gastric polyps
  • colon polyps
  • duodenal ulcers
  • gastroesophageal reflux disease
  • diarrhea
  • loss of appetite
  • elevated amylase
  • elevated lipase
  • elevated AST (GOT)
  • elevated ALT (GPT)
  • elevated GGT
  • elevated ALP
  • proteinuria
  • ketonuria
  • potential hematuria
  • eczema
  • rash
  • pruritus
  • allergic dermatitis
  • arthralgia
  • elevated CK (CPK)
  • increased serum potassium concentration
  • malaise
  • allergic rhinitis
  • elevated serum uric acid
  • peripheral edema
  • shingles
  • limb pain
  • abdominal pain
  • gastritis
  • upper respiratory tract infection
  • tremor
  • headache
  • weakness
  • hunger
  • fatigue
  • facial edema
  • dyspepsia
  • nausea
  • viral upper respiratory tract infection
  • rhinitis
  • diaphoresis
  • diabetic retinopathy
  • visual acuity decrease
  • cough
  • pulmonary congestion
  • dyspnea
  • drug overdose
  • benign prostatic hyperplasia
  • headache
  • cerebral infarction
  • hyperglycemia
  • liver biopsy
  • decreased neutrophils
  • abnormal blood glucose
  • increased blood glucose
  • increased blood pressure
  • hepatic coma
  • lumbar spinal canal stenosis
  • intervertebral disc protrusion
  • intervertebral disc disorder
  • spinal ligament ossification
  • spinal foraminal stenosis
  • rotator cuff syndrome
  • cataract
  • depression
  • iliac artery stenosis
  • dizziness
  • benign prostatic hyperplasia
  • knee surgery
  • nasopharyngitis
  • gastroenteritis
  • influenza
  • uterine pyometra
  • subcutaneous abscess
  • musculoskeletal chest pain
  • falls
  • animal bites
  • radius fracture
  • urticaria
  • glaucoma
  • blurred vision
  • age-related macular degeneration
  • hyperthyroidism
  • hyperparathyroidism
  • angina
  • otalgia
  • iron deficiency anemia
  • food allergy
  • pressure ulcer
  • hearing loss
  • endolymphatic hydrops
  • increased blood creatinine
  • increased blood urea
  • atrial fibrillation
  • hypothyroidism
  • insomnia
  • ovarian cyst
  • vulvar pruritus
  • menopausal symptoms
  • toxic hepatitis
  • chronic cholecystitis
  • non-alcoholic fatty liver disease
  • alcoholic liver disease
  • eyelid injury
  • ligament sprain
  • lip injury
  • contusion

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air exposure, and the temperature should be maintained between 1 and 30 degrees Celsius at room temperature. Proper storage helps maintain the effectiveness of the medication.

Appearance and packaging

Appearance

Orange egg-shaped extended-release film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.